Zura Bio (ZURA) News Today $4.38 -0.02 (-0.45%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Zura Bio to Participate in Two Upcoming Investor Conferences in NovemberOctober 30 at 10:38 AM | businesswire.comReviewing CG Oncology (NASDAQ:CGON) & Zura Bio (NASDAQ:ZURA)October 29, 2024 | americanbankingnews.comZura Bio (NASDAQ:ZURA) Stock, Short Interest ReportOctober 29, 2024 | benzinga.comZura Bio (NASDAQ:ZURA) Stock Quotes, Forecast and News SummaryOctober 29, 2024 | benzinga.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Universal Health (UHS), Apellis Pharmaceuticals (APLS) and Zura Bio (ZURA)October 29, 2024 | markets.businessinsider.comZura Bio (NASDAQ:ZURA) Rating Reiterated by HC WainwrightOctober 23, 2024 | americanbankingnews.comZura Bio’s Leadership Instability and Uncertain Prospects Lead to Hold RatingOctober 23, 2024 | markets.businessinsider.comZura Bio's (ZURA) "Neutral" Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "neutral" rating and issued a $5.00 target price on shares of Zura Bio in a research note on Monday.October 21, 2024 | marketbeat.comNodenza Venture Partners launched - focus on international early-stage and pre-commercial biotech & medtech opportunitiesOctober 17, 2024 | markets.businessinsider.comBullish Zura Bio Insiders Loaded Up On US$1.01m Of StockOctober 17, 2024 | finance.yahoo.comZura Bio Limited (NASDAQ:ZURA) Sees Significant Growth in Short InterestZura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 1,860,000 shares, a growth of 118.9% from the September 15th total of 849,700 shares. Approximately 4.4% of the shares of the company are sold short. Based on an average trading volume of 473,800 shares, the short-interest ratio is currently 3.9 days.October 11, 2024 | marketbeat.comPoint72 Asset Management L.P. Makes New Investment in Zura Bio Limited (NASDAQ:ZURA)Point72 Asset Management L.P. purchased a new stake in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 2,413,127 shares of the company's stock, valued at approximatelOctober 2, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Sees Large Increase in Short InterestZura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 849,700 shares, a growth of 28.1% from the August 31st total of 663,300 shares. Based on an average daily volume of 471,000 shares, the short-interest ratio is presently 1.8 days. Approximately 2.0% of the company's shares are short sold.September 27, 2024 | marketbeat.comArmistice Capital LLC Buys 876,000 Shares of Zura Bio Limited (NASDAQ:ZURA)Armistice Capital LLC raised its stake in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 53.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,524,000 shares of the company's stock afterSeptember 26, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Shares Sold by Affinity Asset Advisors LLCAffinity Asset Advisors LLC trimmed its stake in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) by 50.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 223,335 shares of the company's stock after selling 226,674 shaSeptember 25, 2024 | marketbeat.comAthanor Capital, LP Adjusts Stake in Zura Bio LtdSeptember 24, 2024 | finance.yahoo.comGreat Point Partners LLC Purchases 1,884,501 Shares of Zura Bio Limited (NASDAQ:ZURA)Great Point Partners LLC increased its holdings in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 68.3% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,642,241 shares of the company's stock after buying an additional 1,884,501 shSeptember 24, 2024 | marketbeat.comInstitutions profited after Zura Bio Limited's (NASDAQ:ZURA) market cap rose US$45m last week but private equity firms profited the mostSeptember 20, 2024 | finance.yahoo.comZura Bio (NASDAQ:ZURA) Receives "Overweight" Rating from Piper SandlerPiper Sandler reaffirmed an "overweight" rating and issued a $26.00 target price on shares of Zura Bio in a research note on Thursday.September 19, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Sees Significant Drop in Short InterestZura Bio Limited (NASDAQ:ZURA - Get Free Report) was the target of a significant decline in short interest in August. As of August 31st, there was short interest totalling 663,300 shares, a decline of 83.5% from the August 15th total of 4,020,000 shares. Based on an average daily volume of 318,200 shares, the short-interest ratio is currently 2.1 days. Currently, 2.0% of the shares of the stock are short sold.September 12, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Expected to Earn Q3 2024 Earnings of ($0.18) Per ShareZura Bio Limited (NASDAQ:ZURA - Free Report) - Research analysts at HC Wainwright issued their Q3 2024 EPS estimates for shares of Zura Bio in a report issued on Thursday, September 5th. HC Wainwright analyst M. Kapoor expects that the company will post earnings per share of ($0.18) for the quartSeptember 9, 2024 | marketbeat.comSomeit Sidhu Sells 51,728 Shares of Zura Bio Limited (NASDAQ:ZURA) StockSeptember 7, 2024 | insidertrades.comZura Bio Limited (NASDAQ:ZURA) Director Sells $200,187.36 in StockZura Bio Limited (NASDAQ:ZURA - Get Free Report) Director Someit Sidhu sold 51,728 shares of the firm's stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $3.87, for a total value of $200,187.36. Following the completion of the transaction, the director now directly owns 2,085,418 shares of the company's stock, valued at $8,070,567.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.September 6, 2024 | marketbeat.comHC Wainwright & Co. Initiates Coverage of Zura Bio (ZURA) with Neutral RecommendationSeptember 6, 2024 | msn.comZura Bio (NASDAQ:ZURA) Receives New Coverage from Analysts at HC WainwrightHC Wainwright assumed coverage on shares of Zura Bio in a research report on Thursday. They issued a "neutral" rating and a $5.00 price target on the stock.September 5, 2024 | marketbeat.comZura Bio to Present at Three Upcoming Investor Conferences in SeptemberSeptember 3, 2024 | finance.yahoo.comFY2024 EPS Estimates for Zura Bio Limited (NASDAQ:ZURA) Decreased by AnalystZura Bio Limited (NASDAQ:ZURA - Free Report) - Stock analysts at Chardan Capital reduced their FY2024 EPS estimates for Zura Bio in a research report issued on Tuesday, August 13th. Chardan Capital analyst D. Gataulin now forecasts that the company will post earnings per share of ($0.80) for theAugust 16, 2024 | marketbeat.comZura Bio Reports Second Quarter 2024 Financial Results and Recent Business HighlightsAugust 15, 2024 | finance.yahoo.comZura Bio (NASDAQ:ZURA) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPSZura Bio (NASDAQ:ZURA - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.02).August 14, 2024 | marketbeat.comZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024August 14, 2024 | investorplace.comZura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding WarrantsAugust 12, 2024 | finance.yahoo.comZura Bio Limited (NASDAQ:ZURA) Given Consensus Rating of "Buy" by AnalystsZura Bio Limited (NASDAQ:ZURA - Get Free Report) has been assigned a consensus rating of "Buy" from the six research firms that are currently covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a buy rating and one has given a strong buy rating to the compaAugust 11, 2024 | marketbeat.comZura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its WarrantsAugust 9, 2024 | finance.yahoo.comZura Bio Limited (NASDAQ:ZURA) Short Interest Up 152.1% in JulyZura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a significant increase in short interest in the month of July. As of July 15th, there was short interest totalling 1,790,000 shares, an increase of 152.1% from the June 30th total of 710,100 shares. Based on an average daily volume of 266,100 shares, the short-interest ratio is currently 6.7 days. Approximately 5.4% of the company's shares are sold short.July 26, 2024 | marketbeat.comZura Bio Limited (NASDAQ:ZURA) Receives Average Recommendation of "Buy" from BrokeragesZura Bio Limited (NASDAQ:ZURA - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six brokerages that are currently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recJuly 17, 2024 | marketbeat.comThe 3 Most Undervalued Biotech Stocks to Buy in July 2024July 12, 2024 | investorplace.comZura Bio Limited (NASDAQ:ZURA) Receives Consensus Recommendation of "Buy" from AnalystsZura Bio Limited (NASDAQ:ZURA - Get Free Report) has been given a consensus rating of "Buy" by the six ratings firms that are presently covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating onJune 22, 2024 | marketbeat.comZura Bio Limited Forecasted to Earn FY2024 Earnings of ($0.64) Per Share (NASDAQ:ZURA)Zura Bio Limited (NASDAQ:ZURA - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2024 earnings per share estimates for Zura Bio in a research note issued to investors on Wednesday, June 12th. Cantor Fitzgerald analyst J. Schimmer expects that the company will post earnings perJune 14, 2024 | marketbeat.comZura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024June 14, 2024 | businesswire.comZura Bio Limited (NASDAQ:ZURA) Stake Boosted by Armistice Capital LLCArmistice Capital LLC raised its holdings in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) by 15.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,824,000 shares of the coJune 6, 2024 | marketbeat.comZura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and ImmunologyJune 6, 2024 | businesswire.comZura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024June 3, 2024 | businesswire.comShort Interest in Zura Bio Limited (NASDAQ:ZURA) Expands By 80.1%Zura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a significant increase in short interest in May. As of May 15th, there was short interest totalling 721,400 shares, an increase of 80.1% from the April 30th total of 400,500 shares. Based on an average trading volume of 312,200 shares, the short-interest ratio is currently 2.3 days. Currently, 3.8% of the shares of the company are sold short.May 29, 2024 | marketbeat.comZura Bio Announces Participation in June Investor ConferencesMay 29, 2024 | businesswire.comZura Bio files to sell 41.6M Class A ordinary shares for holdersMay 24, 2024 | msn.comZura Bio Limited (NASDAQ:ZURA) Director Acquires $496,000.00 in StockMay 24, 2024 | insidertrades.com3 Penny Stocks to Buy Now: May 2024May 24, 2024 | investorplace.comZura Bio Limited (NASDAQ:ZURA) Director Van Amstel Arnout Ploos Acquires 80,000 SharesZura Bio Limited (NASDAQ:ZURA - Get Free Report) Director Van Amstel Arnout Ploos bought 80,000 shares of the business's stock in a transaction that occurred on Friday, May 17th. The stock was acquired at an average cost of $6.20 per share, with a total value of $496,000.00. Following the completion of the acquisition, the director now owns 100,000 shares of the company's stock, valued at approximately $620,000. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.May 23, 2024 | marketbeat.comZura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic DevelopmentsMay 10, 2024 | finance.yahoo.comZura Bio (NASDAQ:ZURA) Given New $21.00 Price Target at OppenheimerOppenheimer raised their target price on shares of Zura Bio from $16.00 to $21.00 and gave the company an "outperform" rating in a research note on Friday.May 10, 2024 | marketbeat.com Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here ZURA Media Mentions By Week ZURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZURA News Sentiment▼0.150.43▲Average Medical News Sentiment ZURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZURA Articles This Week▼51▲ZURA Articles Average Week Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABUS News REPL News IMNM News CRMD News TRML News OCS News ABVX News ATXS News YMAB News STOK News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZURA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zura Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZURA Stock Alerts